Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials.

Smith, Timothy R; Spierings, Egilius L H; Cady, Roger; Hirman, Joe; Schaeffler, Barbara; Shen, Vivienne; Sperling, Bjørn; Brevig, Thomas; Josiassen, Mette Krog; Brunner, Elizabeth; Honeywell, Loan; Mehta, Lahar

Smith, Timothy R; Spierings, Egilius L H; Cady, Roger; Hirman, Joe; Schaeffler, Barbara; Shen, Vivienne; Sperling, Bjørn; Brevig, Thomas; Josiassen, Mette Krog; Brunner, Elizabeth; Honeywell, Loan; Mehta, Lahar.

Afiliação

Smith TR; StudyMetrix Research, LLC, 3862 Mexico Road, St. Peters, MO, 63303, USA. tsmith@studymetrix.com.
Spierings ELH; Medvadis Research Corporation, Boston PainCare, Waltham, MA, USA.
Cady R; Lundbeck La Jolla Research Center, San Diego, CA, USA.
Hirman J; Pacific Northwest Statistical Consulting, Inc, Woodinville, WA, USA.
Schaeffler B; Lundbeck Seattle BioPharmaceuticals, Inc, Seattle, WA, USA.
Shen V; Lundbeck LLC, Deerfield, IL, USA.
Sperling B; H. Lundbeck A/S, Copenhagen, Denmark.
Brevig T; H. Lundbeck A/S, Copenhagen, Denmark.
Josiassen MK; H. Lundbeck A/S, Copenhagen, Denmark.
Brunner E; Lundbeck LLC, Deerfield, IL, USA.
Honeywell L; H. Lundbeck A/S, Copenhagen, Denmark.
Mehta L; Lundbeck Seattle BioPharmaceuticals, Inc, Seattle, WA, USA.

J Headache Pain ; 22(1): 46, 2021 May 25.

Article em En | MEDLINE | ID: mdl-34034644

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Headache Pain Assunto da revista: MEDICINA INTERNA / NEUROLOGIA / PSICOFISIOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google